Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeanette A Stewart

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Acta Ophthalmologica Scandinavica|June 13, 2002
Cardiovascular effects of timolol maleate, brimonidine or brimonidine/timolol maleate in concomitant therapyWilliam C Stewart, Jeanette A Stewart, Angi L Jackson
Ophthalmology|September 6, 2005
Corneal thickness after refractive surgeryWilliam C Stewart, Jessica N Jenkins, Jeanette A Stewart
Evidence-Based Medicine|October 19, 2017
What data sources do ophthalmologists trust?William C Stewart, Jeanette A Stewart, Lindsay A Nelson
Journal of Glaucoma|April 3, 2003
Acute and chronic ocular symptoms of dorzolamide 2% compared with placeboWilliam C Stewart, Jeanette A Stewart, Jessica N Leech
Perspectives in Clinical Research|July 3, 2014
Glaucoma clinical trial design: A review of the literatureWilliam C Stewart, Jeanette A Stewart, Lindsay A Nelson
Current Eye Research|April 20, 2011
Ocular surface disease in patients with ocular hypertension and glaucomaWilliam C Stewart, Jeanette A Stewart, Lindsay A Nelson
International Journal of Ophthalmology|June 5, 2018
Ophthalmic community perception of new medication needsWilliam C Stewart, Jeanette A Stewart, Lindsay A Nelson
Acta Ophthalmologica Scandinavica|March 27, 2004
The safety and efficacy of unoprostone 0.15% versus brimonidine 0.2%William C Stewart, Jeanette A Stewart, Douglas G Day, et al.
Current Eye Research|February 23, 2008
Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertensionBarbara Cvenkel, Jeanette A Stewart, Lindsay A Nelson, et al.
Clinical Therapeutics|November 20, 2009
Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot studySriram Sonty, Thomas K Mundorf, Jeanette A Stewart, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Acta Ophthalmologica Scandinavica|June 13, 2002
Cardiovascular effects of timolol maleate, brimonidine or brimonidine/timolol maleate in concomitant therapyWilliam C Stewart, Jeanette A Stewart, Angi L Jackson
Ophthalmology|September 6, 2005
Corneal thickness after refractive surgeryWilliam C Stewart, Jessica N Jenkins, Jeanette A Stewart
Evidence-Based Medicine|October 19, 2017
What data sources do ophthalmologists trust?William C Stewart, Jeanette A Stewart, Lindsay A Nelson
Journal of Glaucoma|April 3, 2003
Acute and chronic ocular symptoms of dorzolamide 2% compared with placeboWilliam C Stewart, Jeanette A Stewart, Jessica N Leech
Perspectives in Clinical Research|July 3, 2014
Glaucoma clinical trial design: A review of the literatureWilliam C Stewart, Jeanette A Stewart, Lindsay A Nelson
Current Eye Research|April 20, 2011
Ocular surface disease in patients with ocular hypertension and glaucomaWilliam C Stewart, Jeanette A Stewart, Lindsay A Nelson
International Journal of Ophthalmology|June 5, 2018
Ophthalmic community perception of new medication needsWilliam C Stewart, Jeanette A Stewart, Lindsay A Nelson
Acta Ophthalmologica Scandinavica|March 27, 2004
The safety and efficacy of unoprostone 0.15% versus brimonidine 0.2%William C Stewart, Jeanette A Stewart, Douglas G Day, et al.
Current Eye Research|February 23, 2008
Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertensionBarbara Cvenkel, Jeanette A Stewart, Lindsay A Nelson, et al.
Clinical Therapeutics|November 20, 2009
Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot studySriram Sonty, Thomas K Mundorf, Jeanette A Stewart, et al.
Pageof 8